8-KOther EventsExhibits & Filings

PFIZER INC 8-K Report, Corporate Update (Aug 15, 2007)

Filed August 15, 2007For Securities:PFE

Summary

This Form 8-K filing by Pfizer Inc. (PFE) on August 15, 2007, primarily announces the submission of XBRL-formatted financial data from its Quarterly Report on Form 10-Q for the period ended July 1, 2007. This submission is part of the SEC's voluntary XBRL pilot program, aimed at testing the eXtensible Business Reporting Language format and its underlying technology. Investors are strongly cautioned that the XBRL data provided in this filing is unaudited and should not be considered a substitute for the official financial statements previously filed with the SEC on August 6, 2007. The purpose of this filing is solely for the technological testing of XBRL. Therefore, this information should not be relied upon for making investment decisions. Investors are directed to the official Form 10-Q filing for accurate and audited financial information pertinent to their investment analysis. The company is complying with SEC regulations regarding the furnishing of this pilot program data, ensuring it does not create liability under Section 18 of the Exchange Act.

Key Highlights

  • 1Pfizer Inc. is participating in the SEC's voluntary XBRL pilot program.
  • 2The filing includes XBRL-formatted financial data from Pfizer's Q2 2007 10-Q filing.
  • 3The XBRL data covers Condensed Consolidated Statements of Income, Balance Sheets, and Cash Flows.
  • 4Investors are explicitly warned that the XBRL data is unaudited and unofficial.
  • 5This information is for technological testing purposes only and should not be used for investment decisions.
  • 6Investors should refer to the official Form 10-Q filed on August 6, 2007, for reliable financial information.

Frequently Asked Questions

The main purpose of this filing is to furnish XBRL-formatted financial data from Pfizer's Quarterly Report on Form 10-Q as part of the SEC's voluntary XBRL pilot program to test new reporting technology.

No, investors are strongly advised not to rely on the XBRL-formatted financial information in this filing for investment decisions. The information is unaudited, unofficial, and intended solely for technological testing.

You should refer to Pfizer's official Quarterly Report on Form 10-Q that was filed with the SEC on August 6, 2007. This document contains the audited financial statements.

XBRL (eXtensible Business Reporting Language) is a global standard for the digital reporting and exchange of business and financial data. It is designed to make financial information more transparent and accessible.